期刊文献+

肾交感神经消融术临床研究进展 被引量:5

The application of catheter-based renal sympathetic denervation in clinical practice:recent progress in clinical research
下载PDF
导出
摘要 近期,肾交感神经消融术(catheter-based renal sympathetic denervation,RDN)的研究成果引起了介入放射学家、血管外科医师的兴趣,亦引起了学术界对肾交感神经在多种疾病发生发展中的用机制亦的重视。此技术不仅为多种以交感神经过度活化为特点的疾病提供了新的治疗方法,也为进一步了解此类疾病的病理生理学研究提供了机会。本文对该技术的研究现状、临床应用、禁忌证、操作步骤、疗效及并发症作一论述。 Recently, the research achievement in catheter- based renal sympathetic denervation technique has greatly attracted the interest of interventional radiologists and vascular surgeons. The academic circles begin to pay more attention to the effect of renal sympathetic nerve activation on the development of various diseases. Catheter-based renal sympathetic nerve ablation provides new therapeutic methods for the disorders that are characterized by excessive sympathetic activation. Moreover, this technique offers certain opportunities for physicians to make researches to further understand the pathophysiology of these diseases. This article aims to make a comprehensive review about the catheter-based renal sympathetic denervation, focusing on its current situation, the clinical application, the contraindications, the operative procedures, the effectiveness, the complications, etc.(J Intervent Radiol, 2013, 22: 001-007)
出处 《介入放射学杂志》 CSCD 北大核心 2013年第1期1-7,共7页 Journal of Interventional Radiology
关键词 肾交感神经 消融 临床应用 并发症 介入放射学 renal sympathetic nerve ablation clinical application complication interventionalradiology
  • 相关文献

参考文献2

二级参考文献32

  • 1Fisher JP,Fadel PJ.Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension[J].Exp Physiol,2010,95: 572 - 580.
  • 2Voskuil M,Verloop WL,Blankestijn PJ,et al.Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience[J].Neth Heart J,2011,19: 319 - 323.
  • 3Osborn JW,Fink GD.Region- specific changes in sympathetic nerve activity in angiotensin II- salt hypertension in the rat[J].Exp Physiol,2010,95: 61 - 68.
  • 4Kearney PM,Whelton M,Reynolds K. Global burden of hypertension:analysis of worldwide data[J].Lancet,2005,(9455):217-223.
  • 5Wolf-Maier K,Cooper RS,Kramer H. Hyperten-sion treatment and control in five European countries,Canada,and the United States[J].Hypertension,2004.10-17.
  • 6Hajjar I,Kotchen TA. Trends in prevalence,awareness,treatment.and control of hypertension in the United States,1988-2000[J].Journal of the American Medical Association,2003,(2):199-206.doi:10.1001/jama.290.2.199.
  • 7Sarafidis PA,Bakris GL. Resistant hypertension:an overview of evaluation and treatment[J].Journal of the American College of Cardiology,2008.1749-1757.
  • 8Smithwick RH. Surgical treatment of hypertension[J].American Journal of Medicine,1948.744-759.doi:10.1016/S0002-9343(48)90397-0.
  • 9Isberg EM,Peet MM. The influence of supradiaphragmatic splanchnicectomy on the heart in hypertension[J].American Heart Journal,1948.567-583.doi:10.1016/0002-8703(48)90643-7.
  • 10Katholi RE. Renal nerves and hypertension:an update[J].Federation Proceedings,1985.2846-2850.

共引文献19

同被引文献43

  • 1卢成志,赵斌,王丽,罗迪.经导管射频消融法去肾动脉交感神经治疗顽固性高血压[J].中国医学前沿杂志(电子版),2012,4(2):18-23. 被引量:5
  • 2嵇程,陈亚珠,潘钢,冯学苏,白景峰.单针水冷式射频消融治疗系统的功率控制及软件实现[J].北京生物医学工程,2004,23(4):281-284. 被引量:6
  • 3Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment [J:. J Am Coil Cardiol, 2008, 52:1749 - 1757.
  • 4Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J]. Circulation, 2008, 51:1403 - 1419.
  • 5Krum H, Schlaich M, Whitboum R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study [J]. Lancet, 2009, 373:1275 - 1281.
  • 6Symplicity HTN- 2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment- resistant hypertension (The Symplieity HTN-2 Trial) : a rando- mised controlled trial[J:. Lancet, 2010, 376:1903 - 1909.
  • 7Krum H, Schlaich MP, Btihm M, et al. Percutaneous renal denervation in patients with treatment- resistant hypertension: final 3-year report of the Symplieity HTN- 1 study [J]. Lancet, 2013, pii : S0140-6736(13)62192-3.
  • 8Jiang X J, Dong H, Liang T, et al. First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approach [J]. EuroIntervention, 2013, 9:684 - 686.
  • 9Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373:1275-1281.
  • 10Esler MD, Krum H, Schlaich M, et al. Renal sympathetic dener- ration for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial[J]. Circulation, 2012, 126: 2976-2982.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部